Next Meeting

Preprogram Reception from 5:30 - 6:30 p.m.,
followed by the Scientific Program from 6:30 - 8:00 p.m.

Both the reception and the academic program will be held in the Sequoia Room
on the 2nd floor of the Moseley Salvatori Conference Center (upstairs from the auditorium).

    

Tuesday, June 8, 2010

Summer Slide Seminar: City of Hope

Massimo D'Apuzzo, MD, PhD
Karl Gaal, MD
Qin Huang, MD
Sharon Wilczynski, MD, PhD

Virtual slide images of each case are available for previewing on www.pathXchange.org from the LASOP homepage under “Groups.”

• To join PathXchange, visit www.pathxchange.org and create an account. Once registered, you will receive an email notifying you that your account is pending approval. After your account has been approved by administration, you will receive a second email with your account details, including your one-time password and a link for immediate access.
• After logging in, you will be redirected to another page where you will be asked to change your password.
• To join the LASOP section, start at the homepage at www.pathxchange.org and select “Groups.” This will direct you to a page citing a long list of member groups (not in alphabetical order).
• Find “LASOP” and select “Join” on the far right under “Join Link.” Good luck. We hope to see you there!

 

Objectives of Program:

 

1.  Develop expertise in the use and limitations of Ki-67 staining in brain tumors.

2.  Apply immunohistochemistry in the differential diagnosis of non-lymphoid primary tumors of the spleen.

3.  Employ diagnostic tools to diagnose a rare hematopietic stem cell disorder.

4.  Use immunohistochemistry to differentiate Merkel cell carcinoma from differential diagnostic considerations and identify the proposed role of polyoma virus in its etiology.

 

Gap Analysis:

 

1.  Community hospital pathologists are often first line diagnosticians of brain tumors, but may not be aware of newer techniques commonly applied in academic centers in changing standards of reporting prognostic factors.

2.  Splenic tumors are rare, but occasionally encountered in general surgical practice, and nonlymphoid tumors are an even rarer subset.  A case that demonstrates differential diagnosis and application of immunochemistry is of benefit to developing members' expertise.

3.  Primary stem cell disorders are rare.  While their diagnosis is usually established in subspecialty environments, recognition of their place in hematopoietic differential diagnosis can help practicing pathologists know when to refer such cases.

4.  Merkel cell carcinoma is a highly deadly skin cancer that can easily be missed by pathologists.  A society member aware of its diagnostic features and use of immunochemistry could save a life.

 

Case based presentations, with images offered to the membership prior to the conference as virtual microscopic unknowns posted on PathXchange.org, will be used to develop the participants' expertise in applying diagnostic knowledge and tools.

 

Identified Need:

 

Identified by membership as valuable for its provision of information in the field of Pathology.

Accreditation:

 

The Los Angeles Society of Pathologists, Inc. is accredited by the Institute for Medical Quality and the California Medical Association to provide continuing medical education for physicians. The Los Angeles Society of Pathologists, Inc. takes responsibility for the content, quality and scientific integrity of this CME activity.

The Los Angeles Society of Pathologists, Inc. designates this educational activity for a maximum of 1.5 AMA PRA Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.

 
 
 

© 2006-2010 Los Angeles Society of Pathologists, Inc.